AND COST-EFFECTIVENESS ANALYSIS OF ADVERSE ATRIAL FIBRILLATION OUTCOME IN TREATING OSTEOPROSIS

被引：2
|
作者：
Kao, Y. H. [1 ]
Chang, L. C. [1 ]
Tsai, Y. W. [1 ]
Chen, L. K. [2 ]
Huang, W. F. [1 ]
机构：
[1] Natl Yang Ming Univ, Taipei 112, Taiwan
[2] Taipei Vet Gen Hosp, Taipei, Taiwan
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.1102
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A217 / A217
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness of radiofrequency catheter ablation for atrial fibrillation
    Chan, Paul S.
    Vijan, Sandeep
    Morady, Fred
    Oral, Hakan
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (12) : 2513 - 2520
  • [22] Evaluating the Cost-effectiveness of Catheter Ablation of Atrial Fibrillation
    Chang, Andrew Y.
    Kaiser, Daniel
    Ullal, Aditya
    Perino, Alexander C.
    Heidenreich, Paul A.
    Turakhia, Mintu P.
    [J]. ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW, 2014, 3 (03) : 177 - 183
  • [23] Cost-Effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation
    Shah, Shimoli V.
    Gage, Brian F.
    [J]. CIRCULATION, 2011, 123 (22) : 2562 - 2570
  • [24] Cost-effectiveness in medical and interventional treatment in atrial fibrillation
    Cohen, A.
    Leclercq, C.
    [J]. ARCHIVES OF CARDIOVASCULAR DISEASES SUPPLEMENTS, 2016, 8 (02) : 144 - 156
  • [25] Cost-effectiveness of bi-atrial pacing for refractory atrial fibrillation
    Sankaranarayanan, R.
    James, M. A.
    Gonna, H.
    Burtchaell, S.
    Holloway, R.
    [J]. HEART, 2008, 94 : A96 - A96
  • [26] Designing an optimal screening program for unknown atrial fibrillation: a cost-effectiveness analysis
    Aronsson, Mattias
    Svennberg, Emma
    Rosenqvist, Marten
    Engdahl, Johan
    Al-Khalili, Faris
    Friberg, Leif
    Frykman, Viveka
    Levin, Lars-Ake
    [J]. EUROPACE, 2017, 19 (10): : 1650 - 1656
  • [27] COST-EFFECTIVENESS ANALYSIS OF APIXABAN IN ATRIAL FIBRILLATION INDICATION: IRAQ (PRIVATE SECTOR)
    Al-Saffar, H.
    Al-Zaidy, M.
    Mohammed, S.
    Al Yassin, A.
    Haji, G.
    Alghadhban, M.
    Shelbaia, M.
    Basu, S.
    Mohamed, O.
    [J]. VALUE IN HEALTH, 2020, 23 : S496 - S496
  • [28] A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke
    Levin, Lars-Ake
    Husberg, Magnus
    Sobocinski, Piotr Doliwa
    Kull, Viveka Frykman
    Friberg, Leif
    Rosenqvist, Marten
    Davidson, Thomas
    [J]. EUROPACE, 2015, 17 (02): : 207 - 214
  • [29] OPORTUNISTIC SCREENING FOR ATRIAL FIBRILLATION IN PRIMARY CARE - A CLINICAL AND COST-EFFECTIVENESS ANALYSIS
    Moran, P.
    Teljeur, C.
    Harrington, P.
    Smith, S.
    Normand, C.
    Ryan, M.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A391 - A391
  • [30] COST-EFFECTIVENESS ANALYSIS OF DABIGATRAN FOR THE PREVENTION OF STROKE IN IRANIAN ATRIAL FIBRILLATION PATIENTS
    Keshavarz, K.
    Meshkini, Hashemi A.
    Nikfar, S.
    Ashkuh, M. S.
    Sanati, E.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A654 - A654
12345